BALCHEM CORP's gross profit margin for the fourth quarter of its fiscal year 2014 is essentially unchanged when compared to the same period a year ago. The company has grown sales and net income significantly, outpacing the average growth rates of competitors within its industry. BALCHEM CORP has average liquidity. Currently, the Quick Ratio is 1.28 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.
During the same period, stockholders' equity ("net worth") has increased by 18.27% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY14||Q4 FY13|
|Net Sales ($mil)||162.67||81.63|
|Net Income ($mil)||19.02||10.75|
|Balance Sheet||Q4 FY14||Q4 FY13|
|Cash & Equiv. ($mil)||50.29||208.75|
|Total Assets ($mil)||861.27||376.87|
|Total Debt ($mil)||332.5||0.0|
|Profitability||Q4 FY14||Q4 FY13|
|Gross Profit Margin||33.2||32.36|
|Return on Assets||6.13||11.9|
|Return on Equity||13.47||13.54|
|Debt||Q4 FY14||Q4 FY13|
|Share Data||Q4 FY14||Q4 FY13|
|Shares outstanding (mil)||30.85||30.23|
|Div / share||0.3||0.26|
|Book value / share||12.71||10.96|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||164562.0||169622.0|
BUY. This stock's P/E ratio indicates a premium compared to an average of 23.02 for the Chemicals industry and a significant premium compared to the S&P 500 average of 20.38. Conducting a second comparison, its price-to-book ratio of 4.13 indicates a premium versus the S&P 500 average of 2.81 and a significant discount versus the industry average of 6.86. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. The valuation analysis reveals that, BALCHEM CORP seems to be trading at a premium to investment alternatives within the industry.
|BCPC 30.84||Peers 23.02||BCPC 18.94||Peers 15.90|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.
BCPC is trading at a significant premium to its peers.
Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
BCPC is trading at a premium to its peers.
|BCPC 18.79||Peers 18.42||BCPC 0.57||Peers 2.45|
Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.
BCPC is trading at a valuation on par with its peers.
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
BCPC trades at a significant discount to its peers.
|BCPC 4.13||Peers 6.86||BCPC 15.64||Peers 12.58|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
BCPC is trading at a significant discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
BCPC is expected to have an earnings growth rate that exceeds its peers.
|BCPC 2.99||Peers 2.36||BCPC 60.56||Peers 0.53|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
BCPC is trading at a significant premium to its industry.
Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.
BCPC has a sales growth rate that significantly exceeds its peers.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV